1-{[3-(5-Methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl}-4-ethylpiperazine, C23H34N6O4S, M=488,60 g/mol
Type: PDE Type 5 Inhibitor)
Trade Name: Levitra®
Treatment of erectile dysfunction and pulmonary arterial hypertonia. Half life 8-12 hours. Effects only after sexual stimulation.
Do not use together with nirate containing medicines or other NO donatating agents ( p.e. Poppers)!
Headache, nausea, dizziness
